Contrast-enhanced pulmonary MR imaging Olav HaraldsethTore AmundsenPeter A. Rinck OriginalPaper Pages: 146 - 153
Gadolinium-containing copolymeric chelates—a new potential MR contrast agent Evan C. UngerDekang ShenTheodore P. Trouard OriginalPaper Pages: 154 - 162
1H-NMRD and17O-NMR assessment of water exchange and rotational dynamics of two potential MRI agents: MP-1177 (an extracellular agent) and MP-2269 (a blood pool agent) K. AdzamliE. TothM. D. Adams OriginalPaper Pages: 163 - 171
P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties Marc PortDominique MeyerLudovic Devoldere OriginalPaper Pages: 172 - 176
Targeting and ultrasound imaging of microbubble-based contrast agents Alexander L. KlibanovMichael S. HughesGary H. Brandenburger OriginalPaper Pages: 177 - 184
Dose and scanning delay using USPIO for central nervous system macrophage imaging Vincent DoussetChristophe GomezJean-Marie Caille OriginalPaper Pages: 185 - 189
Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography Bernd MisselwitzJohannes PlatzekHanns-Joachim Weinmann OriginalPaper Pages: 190 - 195
Real-time imaging and triggering of 3D contrast-enhanced MR angiograms using MR fluoroscopy Stephen J. RiedererSean B. FainReed F. Busse OriginalPaper Pages: 196 - 206
‘NC100150’, a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography Kenneth E. KellarDennis K. FujiiSeymour H. Koenig OriginalPaper Pages: 207 - 213
Interaction of Gd(III) MRI contrast agents with membranes: a review of recent EPR studies Tatyana I. SmirnovaAlex I. SmirnovR. B. Clarkson ReviewPaper Pages: 214 - 229
